The average retail price for Austedo (deutetrabenazine) can vary significantly based on factors such as dosage, quantity, and insurance coverage. The manufacturer-reported list price for a 30-day supply can range from approximately $3,000 to over $5,000 [1].
How can I reduce the cost of Austedo?
Patients seeking to lower their out-of-pocket expenses for Austedo may be eligible for financial assistance programs offered by the manufacturer. The Austedo Savings Card program, for instance, can reduce co-pays for eligible commercially insured patients [1]. For individuals without insurance or with high deductibles, exploring patient assistance programs might offer further cost relief.
When does Austedo's patent expire?
The patent landscape for Austedo is complex and involves multiple patents covering the drug's composition, methods of use, and manufacturing processes. According to DrugPatentWatch.com, patents related to Austedo have expiration dates extending into the future, with some not expiring until well into the 2030s [2]. The exact expiration dates can be influenced by various factors, including patent challenges and regulatory exclusivities.
What are the alternatives to Austedo for Huntington's disease?
For individuals managing Huntington's disease, other treatment options exist besides Austedo. These may include other medications that target chorea symptoms or address broader aspects of the disease. Your healthcare provider can discuss the full range of therapeutic approaches available, considering your specific medical history and symptom profile [3].
What is Austedo used for?
Austedo is a prescription medication approved for the treatment of chorea, which is characterized by involuntary, irregular, and unpredictable jerky movements, associated with Huntington's disease [3]. It is also indicated for the treatment of tardive dyskinesia, a movement disorder that causes a repetitive, involuntary movement of the face, tongue, or other parts of the lower body [3].
How does Austedo work?
Austedo contains deutetrabenazine, which is a reversible inhibitor of the vesicular monoamine transporter type 2 (VMAT2). By inhibiting VMAT2, deutetrabenazine reduces the amount of dopamine released into the synapse, which helps to control involuntary movements associated with Huntington's disease and tardive dyskinesia [3].
What are the side effects of Austedo?
Common side effects associated with Austedo use can include sleepiness, fatigue, insomnia, and depression. More serious side effects may involve suicidal thoughts and behaviors, as well as an increased risk of parkinsonism and QT interval prolongation. It is crucial for patients to discuss any potential side effects with their healthcare provider [3].
Can Austedo be used in children?
The safety and effectiveness of Austedo have not been established in pediatric patients for Huntington's disease. For tardive dyskinesia, its use in pediatric patients has been studied, and it is approved for patients aged 6 years and older [3].
*
**Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/